Iteos Therapeutics Inc (ITOS)

04:20 AM

ITOS stock touches 52-week low at $7.09 amid market challenges - MSN

04:20 AM

Feb 20, 2025

Short Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Increases By 5.2% - MarketBeat

Feb 20, 2025

Feb 20, 2025

Empowered Funds LLC Grows Stock Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Feb 20, 2025

Feb 18, 2025

Short Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Grows By 5.2% - Defense World

Feb 18, 2025

Feb 17, 2025

(ITOS) Investment Analysis and Advice - Stock Traders Daily

Feb 17, 2025

Feb 16, 2025

Peapod Lane Capital LLC Invests $836,000 in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Feb 16, 2025

Feb 13, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Acquired by SG Americas Securities LLC - Defense World

Feb 13, 2025

Feb 06, 2025

When (ITOS) Moves Investors should Listen - Stock Traders Daily

Feb 06, 2025

Feb 04, 2025

We Think iTeos Therapeutics (NASDAQ:ITOS) Needs To Drive Business Growth Carefully - Yahoo Finance

Feb 04, 2025

Feb 04, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Sees Significant Decline in Short Interest - MarketBeat

Feb 04, 2025

Jan 26, 2025

(ITOS) Proactive Strategies - Stock Traders Daily

Jan 26, 2025

Jan 18, 2025

JPMorgan Chase & Co. Purchases 5,368 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jan 18, 2025

Jan 18, 2025

HC Wainwright Reaffirms “Buy” Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Jan 18, 2025

Jan 17, 2025

Short Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Declines By 21.1% - MarketBeat

Jan 17, 2025

Jan 17, 2025

All You Need to Know About iTeos Therapeutics (ITOS) Rating Upgrade to Buy - MSN

Jan 17, 2025

Jan 16, 2025

iTeos Therapeutics' (ITOS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Jan 16, 2025

Jan 16, 2025

(ITOS) On The My Stocks Page - Stock Traders Daily

Jan 16, 2025

Jan 14, 2025

Barclays PLC Has $1.16 Million Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Jan 14, 2025

Jan 14, 2025

Invivyd (NASDAQ:IVVD) vs. iTeos Therapeutics (NASDAQ:ITOS) Head-To-Head Comparison - Defense World

Jan 14, 2025

Jan 13, 2025

Iteos Therapeutics advances anti-TREM2 monoclonal antibody toward IND filing - BioWorld Online

Jan 13, 2025

Jan 13, 2025

iTeos Therapeutics Plans 2025 Data Presentation on Therapies - TipRanks

Jan 13, 2025

Jan 12, 2025

iTeos Therapeutics to raise $120 million via registered direct offering - MSN

Jan 12, 2025

Jan 12, 2025

Wedbush Reaffirms Outperform Rating for iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Jan 12, 2025

Jan 11, 2025

iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Informazione.it

Jan 11, 2025

Jan 11, 2025

iTeos annonce ses priorités stratégiques et ses étapes clés prévues pour 2025 - GlobeNewswire Inc.

Jan 11, 2025

Jan 10, 2025

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones - GlobeNewswire

Jan 10, 2025

Jan 10, 2025

iTeos Therapeutics' (ITOS) "Outperform" Rating Reaffirmed at Wedbush - MarketBeat

Jan 10, 2025

Jan 10, 2025

iTeos Unveils Ambitious 2025 Cancer Drug Pipeline: Multiple Phase 2 Readouts, $684M Cash Runway - StockTitan

Jan 10, 2025

Jan 08, 2025

iTeos Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 08, 2025

Jan 05, 2025

Trading (ITOS) With Integrated Risk Controls - Stock Traders Daily

Jan 05, 2025

Jan 04, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Bought by Geode Capital Management LLC - Defense World

Jan 04, 2025

Jan 03, 2025

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Holdings Trimmed by Franklin Resources Inc. - Defense World

Jan 03, 2025

Dec 30, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Stock Holdings Lessened by Barclays PLC - Defense World

Dec 30, 2024

Dec 29, 2024

Reviewing Calidi Biotherapeutics (NYSE:CLDI) & iTeos Therapeutics (NASDAQ:ITOS) - Defense World

Dec 29, 2024

Dec 26, 2024

State Street Corp Increases Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Dec 26, 2024

Dec 26, 2024

State Street Corp Increases Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS) - MarketBeat

Dec 26, 2024

Dec 25, 2024

Trend Tracker for (ITOS) - Stock Traders Daily

Dec 25, 2024

Dec 21, 2024

Wells Fargo & Company Has Lowered Expectations for iTeos Therapeutics (NASDAQ:ITOS) Stock Price - Defense World

Dec 21, 2024

Dec 21, 2024

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 21, 2024

Dec 20, 2024

iTeos Therapeutics price target lowered to $19 from $31 at Wells Fargo - Yahoo Finance

Dec 20, 2024

Dec 19, 2024

iTeos Therapeutics (NASDAQ:ITOS) Price Target Cut to $19.00 by Analysts at Wells Fargo & Company - MarketBeat

Dec 19, 2024

Dec 18, 2024

Inupadenant “deprioritised” by iTeos in favour of pipeline TIGIT therapy - MSN

Dec 18, 2024

Dec 17, 2024

Merck, iTeos dropping assets, Viridian data — BioCentury’s Clinical Report - BioCentury

Dec 17, 2024

Dec 17, 2024

iTeos Therapeutics: A Perhaps Unjustified Decline To End 2024 - Seeking Alpha

Dec 17, 2024

Dec 17, 2024

Merck & Co. Calls Time On Flop TIGIT And LAG-3 Programs - News & Insights

Dec 17, 2024

Dec 16, 2024

Charles Schwab Investment Management Inc. Buys 8,397 Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) - Defense World

Dec 16, 2024

Dec 16, 2024

iTeos Therapeutics’ (ITOS) Buy Rating Reiterated at HC Wainwright - Defense World

Dec 16, 2024